Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Background: Effective antiplatelet therapy is critical for patients with ST-segment elevation myocardial infarction (STEMI) and receiving primary percutaneous coronary interventions (PPCI). Intracoronary (IC) and intravenous (IV) administration of tirofiban are commonly used during the procedure of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Rui Tian, Rugang Liu, Jiajun Zhang, Yong Li, Shujian Wei, Feng Xu, Xiaoxing Li, Chuanbao Li
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-05-01
Col·lecció:	Heliyon
Matèries:	ST-elevation myocardial infarction Percutaneous coronary intervention Tirofiban Meta-analysis Randomized controlled trial
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2405844023030499
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!